Search Results - "HOLLIS, Donna R"

Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301 by MILLER, Antonius A, MURRY, Daryl J, LEWIS, Lionel D, FAKIH, Marwan G, EDELMAN, Martin J, MILLARD, Fred, FRANK, Richard C, HOHL, Raymond J, RATAIN, Mark J, OWZAR, Kouros, HOLLIS, Donna R, KENNEDY, Erin B, ABOU-ALFA, Ghassan, DESAI, Apurva, HWANG, Jimmy, VILLALONA-CALERO, Miguel A, DEES, E. Claire

“…We sought to characterize the pharmacokinetics (PK) and determine a tolerable dose of oral sorafenib in patients with hepatic or renal dysfunction. Patients…”
Get full text

Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481) by KEMENY, Nancy E, NIEDZWIECKI, Donna, MAYER, Robert J, HOLLIS, Donna R, LENZ, Heinz-Josef, WARREN, Robert S, NAUGHTON, Michelle J, WEEKS, Jane C, SIGURDSON, Elin R, HERNDON, James E, CHUNFENG ZHANG

“…Hepatic metastases derive most of their blood supply from the hepatic artery; therefore, for patients with hepatic metastases from colorectal cancer, hepatic…”
Get full text

Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, Docetaxel, or Irinotecan in Patients With Metastatic Pancreatic Cancer: CALGB 89904 by KULKE, Matthew H, TEMPERO, Margaret A, NIEDZWIECKI, Donna, HOLLIS, Donna R, KINDLER, HedyL, CUSNIR, Michael, ENZINGER, Peter C, GORSCH, Stefan M, GOLDBERG, Richard M, MAYER, Robert J

“…The relative value of gemcitabine-based combination chemotherapy therapy and prolonged infusions of gemcitabine in patients with advanced pancreatic cancer…”
Get full text

Impact of Body Mass Index on Outcomes and Treatment-Related Toxicity in Patients With Stage II and III Rectal Cancer: Findings From Intergroup Trial 0114 by MEYERHARDT, Jeffrey A, TOPPER, Joel E, MACDONALD, John S, BENSON, Al B, FUCHS, Charles S, NIEDZWIECKI, Donna, HOLLIS, Donna R, MCCOLLUM, A. David, BRADY, Denise, O'CONNELL, Michael J, MAYER, Robert J, CUMMINGS, Bernard, WILLETT, Christopher

“…To study the relationship between body mass index (BMI) and rates of sphincter-preserving operations, overall survival, cancer recurrence, and…”
Get full text

Multivitamin Use Is Not Associated With Cancer Recurrence or Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 by NG, Kimmie, MEYERHARDT, Jeffrey A, HANTEL, Alexander, GOLDBERG, Richard M, FUCHS, Charles S, CHAN, Jennifer A, NIEDZWIECKI, Donna, HOLLIS, Donna R, SALTZ, Leonard B, MAYER, Robert J, BENSON, Al B, SCHAEFER, Paul L, WHITTOM, Renaud

“…Multivitamin use is widespread in the United States, especially among patients with cancer. However, the influence of multivitamin supplementation on cancer…”
Get full text

Phase I and Pharmacokinetic Study of Erlotinib for Solid Tumors in Patients With Hepatic or Renal Dysfunction: CALGB 60101 by MILLER, Antonius A, MURRY, Daryl J, LICHTMAN, Stuart M, RATAIN, Mark J, OWZAR, Kouros, HOLLIS, Donna R, LEWIS, Lionel D, KINDLER, Hedy L, MARSHALL, John L, VILLALONA-CALERO, Miguel A, EDELMAN, Martin J, HOHL, Raymond

“…We investigated dose and pharmacokinetics of erlotinib in patients with hepatic dysfunction or renal dysfunction. Patients were assigned to one of three…”
Get full text

Regional Lung Density Changes After Radiation Therapy for Tumors in and Around Thorax by Ma, Jinli, M.D, Zhang, Junan, Ph.D, Zhou, Sumin, Ph.D, Hubbs, Jessica L., M.S, Foltz, Rodney J., M.D, Hollis, Donna R., M.S, Light, Kim L., C.M.D, Wong, Terence Z., M.D, Kelsey, Christopher R., M.D, Marks, Lawrence B., M.D

“…Purpose To study the temporal nature of regional lung density changes and to assess whether the dose-dependent nature of these changes is associated with…”
Get full text

Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis by Kocak, Zafer, M.D, Borst, Gerben R., M.D, Zeng, Jing, B.S, Zhou, Sumin, Ph.D, Hollis, Donna R., M.S, Zhang, Junan, Ph.D, Evans, Elizabeth S., B.S, Folz, Rodney J., M.D., Ph.D, Wong, Terrence, M.D., Ph.D, Kahn, Daniel, Ph.D, Belderbos, Jose S.A., M.D, Lebesque, Joos V., M.D., Ph.D, Marks, Lawrence B., M.D

“…Purpose: Clinical and 3D dosimetric parameters are associated with symptomatic radiation pneumonitis rates in retrospective studies. Such parameters include:…”
Get full text

Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer by Evans, Elizabeth S, Prosnitz, Robert G, Yu, Xiaoli, Zhou, Su-Min, Hollis, Donna R, Wong, Terence Z, Light, Kim L, Hardenbergh, Patricia H, Blazing, Michael A, Marks, Lawrence B

“…The aim of this study was to assess the impact of patient-specific factors, left ventricle (LV) volume, and treatment set-up errors on the rate of perfusion…”
Get more information

Impact of Hospital Procedure Volume on Surgical Operation and Long-Term Outcomes in High-Risk Curatively Resected Rectal Cancer: Findings From the Intergroup 0114 Study by MEYERHARDT, Jeffrey A, TEPPER, Joel E, MACDONALD, John S, BENSON, Al B, FUCHS, Charles S, NIEDZWIECKI, Donna, HOLLIS, Donna R, SCHRAG, Deborah, AYANIAN, John Z, O'CONNELL, Michael J, WEEKS, Jane C, MAYER, Robert J, WILLETT, Christopher G

“…Prior studies have demonstrated superior outcomes after a curative surgical resection of rectal cancer at hospitals where the volume of such surgeries is high…”
Get full text

Association Between RT-Induced Changes in Lung Tissue Density and Global Lung Function by Ma, Jinli, M.D, Zhang, Junan, Ph.D, Zhou, Sumin, Ph.D, Hubbs, Jessica L., M.S, Foltz, Rodney J., M.D, Hollis, Donna R., M.S, Light, Kim L., C.M.D., R.T.T, Wong, Terence Z., M.D, Kelsey, Christopher R., M.D, Marks, Lawrence B., M.D

“…Purpose To assess the association between radiotherapy (RT)-induced changes in computed tomography (CT)-defined lung tissue density and pulmonary function…”
Get full text

A Comparison of the Pharmacokinetics and Pharmacodynamics of Docetaxel between African-American and Caucasian Cancer Patients: CALGB 9871 by LEWIS, Lionel D, MILLER, Antonius A, OTTERSON, Gregory A, MILLARD, Frederick, RATAIN, Mark J, ROSNER, Gary L, DOWELL, Jonathan E, VALDIVIESO, Manuel, RELLING, Mary V, EGORIN, Merrill J, BIES, Robert R, HOLLIS, Donna R, LEVINE, Ellis G

“…Purpose: Increased clearance of drugs, such as oral cyclosporine, that are CYP3A and/or ABCB1 (P-gp/MDR1) substrates was reported in African-American compared…”
Get full text

The Impact of Induction Chemotherapy and the Associated Tumor Response on Subsequent Radiation-Related Changes in Lung Function and Tumor Response by Mao, Jingfang, M.D, Kocak, Zafer, M.D, Zhou, Sumin, Ph.D, Garst, Jennifer, M.D, Evans, Elizabeth S., B.S, Zhang, Junan, Ph.D, Larrier, Nicole A., M.D, Hollis, Donna R., M.S, Folz, Rodney J., M.D., Ph.D, Marks, Lawrence B., M.D

“…Purpose: To assess the impact of induction chemotherapy, and associated tumor shrinkage, on the subsequent radiation-related changes in pulmonary function and…”
Get full text

Updated assessment of the six-minute walk test as predictor of acute radiation-induced pneumonitis by Mao, Jingfang, M.D, Zhang, Junan, Ph.D, Zhou, Sumin, Ph.D, Das, Shiva, Ph.D, Hollis, Donna R., M.S, Folz, Rodney J., M.D., Ph.D, Wong, Terence Z., M.D., Ph.D, Marks, Lawrence B., M.D

“…Purpose: To assess the utility of the 6-minute walk test (6MWT) as a predictor of symptomatic radiation-induced pneumonitis (RP). Methods: As part of a…”
Get full text

Prospective assessment of radiotherapy‐associated cardiac toxicity in breast cancer patients: Analysis of data 3 to 6 years after treatment by Prosnitz, Robert G., Hubbs, Jessica L., Evans, Elizabeth S., Zhou, Su‐Min, Yu, Xiaoli, Blazing, Michael A., Hollis, Donna R., Tisch, Andrea, Wong, Terence Z., Borges‐Neto, Salvador, Hardenbergh, Patricia H., Marks, Lawrence B.

“…BACKGROUND. Radiation therapy (RT) to the left breast/chest wall has been linked with cardiac dysfunction. Previously, the authors identified cardiac perfusion…”
Get full text

A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903 by Posner, Mitchell C., Niedzwiecki, Donna, Venook, Alan P., Hollis, Donna R., Kindler, Hedy L., Martin, Edward W., Schilsky, Richard L., Goldberg, Richard M.

“…Background Patients with curatively resected colorectal cancer hepatic metastases often harbor occult metastatic disease and are at high risk of experiencing…”
Get full text

Radiation-induced narrowing of the tracheobronchial tree: An in-depth analysis by Kelsey, Chris R., Kahn, Daniel, Hollis, Donna R., Miller, Keith L., Zhou, Su-min, Clough, Robert W., Marks, Lawrence B.

“…Symptomatic narrowing of the tracheobronchial tree is not a common clinical problem after conventional-dose external beam radiation therapy but has been…”
Get full text

CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer by Krasna, Mark J, Reed, Carolyn E, Nedzwiecki, Donna, Hollis, Donna R, Luketich, James D, DeCamp, Malcolm M, Mayer, Robert J, Sugarbaker, David J

“…Background. The staging of esophageal cancer is imprecise. Thoracoscopic/laparoscopic (TS/LS) staging has been proposed as a more accurate lymph node (LN)…”
Get full text

A Phase II Prospective Multi-Institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903 by Posner, Mitchell C., Niedzwiecki, Donna, Venook, Alan P., Hollis, Donna R., Kindler, Hedy L., Martin, Edward W., Schilsky, Richard L., Goldberg, Richard M., Mayer, Robert J.

“…The online version of the original article can be found under doi: 10.1245/s10434-007-9654-7…”
Get full text

A phase i trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: Report of cancer and leukemia group B 9661 by FLEMING, Gini F, MEROPOL, Neal J, RATAIN, Mark J, ROSNER, Gary L, HOLLIS, Donna R, CARSON, William E, CALIGIURI, Michael, MORTIMER, Joanne, TKACZUK, Katherine, PARIHAR, Robin, SCHILSKY, Richard L

“…The purpose of this study was to determine the toxicity of escalating doses of trastuzumab when combined with a fixed dose regimen of interleukin (IL)-2…”
Get full text